Literature DB >> 15293095

Continuity of cytokine activation in patients with familial Mediterranean fever.

Sait Bagci1, Bulent Toy, Ahmet Tuzun, Yuksel Ates, Murat Aslan, Ali Inal, Mustafa Gulsen, Necmettin Karaeren, Kemal Dagalp.   

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited inflammatory disorder, characterized by recurrent attacks of fever and polyserositis. It has been considered that miscellaneous cytokines take part in the pathogenesis of the disease. The aim of this study was to investigate serum levels of soluble interleukin-2 receptor (sIL-2R), interleukin-6 (IL-6), and interleukin-10 (IL-10) in patients with FMF. The study included 42 patients with FMF (3 females, 39 males, mean age: 24.43 years) and 20 healthy volunteers as the control group (18 males, 2 females, mean age: 23.2 years). The patients were chosen according to Eliakim criteria. After recording their history and performing an examination, leukocyte counts, erythrocyte sedimentation rates (ESR), C-reactive protein (CRP), fibrinogen, sIL-2R, IL-6, and IL-10 levels were measured before and during attacks. A significant increase was found in leukocyte ( p<0.001), ESR ( p<0.001), CRP ( p<0.001), and fibrinogen ( p<0.001) levels of the patient group in the attack period compared to those in the quiescent state. sIL-2R ( p=0.019) and IL-6 ( p<0.001) levels showed significant increases during attacks compared to the levels before an attack. There was no significant difference between IL-10 levels. The levels of the three cytokines were significantly high both before and during the attacks compared to the control group. As a result, the elevation of sIL-2R and IL-6 levels both before and during the attacks compared to control group suggests the existence of continuous cytokine activation in the patients. No significant increase in the IL-10 levels in spite of the significant rise of sIL-2R and IL-6 during attacks supports the notion of inflammation and also reveals that compensation by anti-inflammatory IL-10 does not seem to occur.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293095     DOI: 10.1007/s10067-004-0925-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Tumor necrosis factor in familial Mediterranean fever.

Authors:  E Ozyilkan; H Simsek; H Telatar
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965

2.  The soluble interleukin-2 receptor in rheumatic disease.

Authors:  L A Rubin
Journal:  Arthritis Rheum       Date:  1990-08

Review 3.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

Review 4.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

5.  Immunoregulatory abnormalities in familial Mediterranean fever.

Authors:  D Ilfeld; S Weil; O Kuperman
Journal:  Clin Immunol Immunopathol       Date:  1981-02

6.  Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.

Authors:  E Erken; R Güneşaçar; S Ozbek; K Konca
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

7.  Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.

Authors:  D H Campen; D A Horwitz; F P Quismorio; G R Ehresmann; W J Martin
Journal:  Arthritis Rheum       Date:  1988-11

8.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Authors:  H Tilg; E Trehu; M B Atkins; C A Dinarello; J W Mier
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

9.  Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

Authors:  S Kiraz; I Ertenli; M Arici; M Calgüneri; I Haznedaroglu; I Celik; S Pay; S Kirazli
Journal:  Clin Exp Rheumatol       Date:  1998 Nov-Dec       Impact factor: 4.473

10.  Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  J P Drenth; M van Deuren; J van der Ven-Jongekrijg; C G Schalkwijk; J W van der Meer
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  20 in total

1.  Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever.

Authors:  Mehmet Celikbilek; Serkan Dogan; Lutfi Akyol; Elif Borekci; Gokmen Zararsiz; Mustafa Kozan; Ilhan Gunaydin
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.

Authors:  Eren Erken; Huseyin T E Ozer; Ramazan Gunesacar
Journal:  Rheumatol Int       Date:  2006-01-06       Impact factor: 2.631

3.  Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: Original article.

Authors:  Fatma Duksal; Demet Alaygut; Ahmet Sami Güven; Mahmut Ekici; Mehmet Burhan Oflaz; Rukiye Tuncer; Ömer Cevit
Journal:  Eur J Rheumatol       Date:  2015-03-01

4.  Cardiac autonomic functions in children with familial Mediterranean fever.

Authors:  Murat Şahin; Mustafa Kır; Balahan Makay; Pembe Keskinoğlu; Elçin Bora; Erbil Ünsal; Nurettin Ünal
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

5.  Evaluation of the mean platelet volume in children with familial Mediterranean fever.

Authors:  Seçil Arıca; Cahit Ozer; Vefik Arıca; Ali Karakuş; Tanju Celik; Ramazan Güneşaçar
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

6.  Mean platelet volume in children with familial Mediterranean fever.

Authors:  Balahan Makay; Zeynep Türkyilmaz; Erbil Unsal
Journal:  Clin Rheumatol       Date:  2009-03-13       Impact factor: 2.980

7.  Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.

Authors:  Vildan Bostanci; Hulya Toker; Soner Senel; Omer Poyraz; Aysun Akpinar; Emine Pirim Görgün; Olcay Bakar
Journal:  Clin Oral Investig       Date:  2016-04-11       Impact factor: 3.573

8.  TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever.

Authors:  Melia Z Karakose; Suna Yapali; Esin Salman; Kenan Aksu; Süleyman Karakose; Ulus S Akarca
Journal:  Clin Rheumatol       Date:  2014-09-12       Impact factor: 2.980

Review 9.  Cardiac disease in familial Mediterranean fever.

Authors:  Eren Erken; Ertugrul Erken
Journal:  Rheumatol Int       Date:  2017-10-20       Impact factor: 2.631

10.  Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients.

Authors:  Serpil Muge Deger; Mehmet Akif Ozturk; Mehmet D Demirag; Selcuk Aslan; Berna Goker; Seminur Haznedaroglu; A Mesut Onat
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.